Table 1.
Number of isolates according to MIC (μg ml–1) |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
<0.03 |
0.03 |
0.06 |
0.12 |
0.25 |
0.5 |
1 |
2 |
4 |
8 |
16 |
32 |
64 |
128 |
256 |
|
Ceftriaxone* |
26 |
7 |
8 |
5 |
– |
2 |
2 |
– |
– |
– |
– |
– |
– |
– |
– |
Cefixime* |
22 |
9 |
3 |
2 |
5 |
5 |
– |
4 |
– |
– |
– |
– |
– |
– |
– |
Azithromycin† |
– |
– |
4 |
4 |
13 |
12 |
2 |
6 |
2 |
6 |
– |
– |
– |
1 |
– |
Tetracycline‡ |
– |
– |
– |
2 |
5 |
11 |
9 |
20 |
– |
1 |
2 |
– |
– |
– |
– |
Fosfomycin§ |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
19 |
27 |
3 |
1 |
– |
*Susceptible, ≤0.25 µg ml−1; non-susceptible, ≥0.5 µg ml−1.
†Susceptible, ≤1 µg ml−1; non-susceptible, ≥2 µg ml−1.
‡Susceptible, ≤0.25 µg ml−1; intermediate, 0.5–1 µg ml−1; resistant, ≥2 µg ml−1.
§No interpretative criteria have been published by the CLSI.